
Opinion|Videos|August 16, 2024
Role of Biomarker and Genetic Testing in Prostate Cancer Diagnosis
The panel emphasizes the crucial need for swift biomarker and genetic testing to facilitate timely and effective patient care in prostate cancer management.
Advertisement
Episodes in this series

Video content above is prompted by the following question:
- What is the role for biomarker and genetic testing in diagnosing prostate cancer?
- When during the disease course do you test for biomarkers?
Newsletter
Stay current with the latest urology news and practice-changing insights — sign up now for the essential updates every urologist needs.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Urology Times
1
Mohit Khera, MD, recaps key takeaways from FDA panel on TRT for men
2
FDA approves niraparib plus abiraterone acetate with prednisone for BRCA2+ mCSPC
3
FDA approves first-line Zenflow system for the treatment of BPH
4
FDA approves zoliflodacin for uncomplicated urogenital gonorrhea
5























